BRIDGEWAY CAPITAL MANAGEMENT, LLC - MILLENDO THERAPEUTICS INC ownership

MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 58 filers reported holding MILLENDO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of MILLENDO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$197,000
-44.0%
164,3000.0%0.00%
-42.9%
Q4 2020$352,000
+31.3%
164,3000.0%0.01%
+16.7%
Q3 2020$268,000
-7.3%
164,3000.0%0.01%0.0%
Q2 2020$289,000164,3000.01%
Other shareholders
MILLENDO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,396,615$16,145,0004.14%
GREAT POINT PARTNERS LLC 1,288,093$14,891,000,0001.65%
NEA Management Company, LLC 1,766,779$20,424,0001.43%
Bpifrance SA 1,078,670$12,469,0001.34%
ADAMS STREET PARTNERS LLC 409,146$4,730,0000.88%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,825$2,056,0000.76%
Prosight Management, LP 73,868$854,0000.43%
Samsara BioCapital, LLC 45,101$521,0000.34%
AWM Investment Company, Inc. 77,629$897,0000.17%
GMT CAPITAL CORP 53,419$618,0000.02%
View complete list of MILLENDO THERAPEUTICS INC shareholders